Biotest Diagnostics Corp.

Biotest Diagnostics Corporation is the U.S. subsidiary of Biotest AG which has worldwide sales in excess of $200 million and employs over 1000 people. We are involved in the development, production and marketing of pharmaceutical and medical diagnostic products.

Pharmaceutical and diagnostics are dynamic industries requiring continual investment in research and development. Our R & D efforts are focused in the areas of blood typing, tissue typing (HLA), infectious disease diagnostics, environmental monitoring and a new generation of therapeutic immunoglobulins. Our internal R & D programs are supplemented by cooperation with international partners providing us with a broad range of technical innovations.

Biotest Diagnostics Corporation specializes in the areas of environmental monitoring, transplant immunology, infectious disease diagnostics, monoclonal antibodies for cancer research and IL-2 (T-cell growth factor) which is used in AIDS research.